From the press release archive
Medicine 2023-06-28 1 min read

Intranasal insulin treatment might boost cognition in people with mild cognitive impairment or Alzheimer's Disease, according to meta-analysis of 29 studies across multiple disorders

Published 2023-06-28 · Original archive entry · Explore research explainers
Intranasal insulin treatment might boost cognition in people with mild cognitive impairment or Alzheimer's Disease, according to meta-analysis of 29 studies across multiple disorders

###

Article URL:  https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0286887

Article Title: Outcomes and clinical implications of intranasal insulin on cognition in humans: A systematic review and meta-analysis

Author Countries: Canada

Funding: The authors received no specific funding for this work.

END
From the original Press-News collection. Issuers of news releases are responsible for the accuracy of their content.